Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) Short Interest Down 9.2% in October

Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 1,242,600 shares, a decrease of 9.2% from the September 30th total of 1,368,900 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Jacobio Pharmaceuticals Group Price Performance

Shares of JBPHF opened at $0.30 on Friday. Jacobio Pharmaceuticals Group has a twelve month low of $0.30 and a twelve month high of $0.30. The firm’s 50 day moving average price is $0.30 and its 200 day moving average price is $0.30.

About Jacobio Pharmaceuticals Group

Jacobio Pharmaceuticals Group Co, Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein.